Previous
Previous Product Image

Hexarelin (5mg)

$59.99
Next

GLP-3 RT 10mg (12mg) 10-Pack

Original price was: $1,299.99.Current price is: $859.98.
Next Product Image

CagriRETA Blend 10mg (Cagrilintide + GLP-3 RT)

Original price was: $139.99.Current price is: $119.99.

CagriReta Blend 10mg (Cagrilintide + GLP-3 RT)

Cagrilintide
Container Glass Vial
Presentation Lyophilized Powder
Molecular Formula C267H409N75O80
Molecular Weight 5651.9 g/mol
PubChem CID Not Available
CAS Number 1339615-92-9
Synonyms AM833, Cagrilintide

 

GLP-3 RT
Container Glass Vial
Presentation Lyophilized Powder
Molecular Formula C331H492N86O100
Molecular Weight 7461.14 g/mol
PubChem CID 166598099
CAS Number 2381089-83-2
Synonyms LY3437943, GLP-3 RT

Description

This product is prepared for LABORATORY RESEARCH USE ONLY and may not be used for other purposes.


Product Overview

CagriReta Blend 10mg combines two innovative investigational peptides, Cagrilintide and GLP-3 RT, designed for research into metabolic health, appetite regulation, and weight management. This unique dual formula provides researchers with a novel tool to study complementary mechanisms of action targeting both satiety and energy regulation.


What is CagriReta?

  • Cagrilintide – A long-acting amylin analogue studied for its role in appetite suppression and weight regulation.

  • GLP-3 RT – A triple-agonist (GLP-1, GIP, and glucagon receptor) that has shown promise in preclinical and early clinical research for weight reduction, glucose regulation, and metabolic health.

When combined, these compounds may provide synergistic effects in weight management research by addressing both hunger signaling and metabolic pathways.


Key Research Areas

  • Appetite Regulation – Studies show cagrilintide may enhance satiety, while GLP-3 RT targets multiple hormonal pathways influencing energy intake.

  • Weight Management Research – Combination therapy is being investigated for more effective fat reduction compared to single agents.

  • Metabolic Health – Potential impacts on glucose regulation, insulin sensitivity, and lipid metabolism.

  • Endocrine Pathways – Provides insight into amylin, GLP-1, GIP, and glucagon receptor signaling.


Potential Benefits in Research

  • Dual-acting blend targeting appetite and metabolism.

  • Extended activity for exploring long-term metabolic regulation.

  • Unique opportunity to study combination peptide therapies.


Product Specifications

Specification Details
Product Name CagriReta Blend
Quantity 10mg per vial
Container Glass Vial
Presentation Lyophilized Powder
Components Cagrilintide + GLP-3 RT
Research Applications Appetite Regulation, Weight Management, Glucose & Lipid Metabolism, Endocrine Research

Usage Notes

This compound is supplied as a lyophilized powder and is intended solely for laboratory-based investigations. Reconstitution and handling should be performed only by qualified professionals in a controlled research setting.


Legal Disclaimer

This product is prepared and sold exclusively for laboratory research purposes. It is not intended for human consumption, medical use, or as a dietary supplement. The information provided is for educational purposes only. None of the statements on this page have been evaluated by the FDA.

Shopping cart

2

Subtotal: $119.98

View cartCheckout